Allergy, Asthma & Clinical Immunology

Casa
Argentina
Buenos Aires
Allergy, Asthma & Clinical Immunology

Scientific Information and News about Allergy, Asthma & Immunology worldwide

28/04/2026

( ) programme is providing over 80% protection for newborn infants, including those born prematurely. https://www.gov.uk/government/news/rsv-maternal-vaccine-cuts-baby-hospital-admissions-by-up-to-85

28/04/2026

Unsupervised comprehensive reveal distinct in : insights from two prospective cohorts Open Access. https://interasma.org/2026/04/28/unsupervised-comprehensive-ct-imaging-clusters-reveal-distinct-morphological-phenotypes-in-asthma-insights-from-two-prospective-cohorts/

28/04/2026

in - This from the Bronchiectasis Section of the Disorders Network describes biomarkers in bronchiectasis. https://ivancevichmd.blogspot.com/2026/04/biomarkers-in-bronchiectasis-infographic.html

27/04/2026

, either alone or in combination with (SCIT) for (HDMs), was associated with improved clinical outcomes over 36 months in patients with HDM-sensitized mild-to-moderate . https://www.medscape.com/viewarticle/omalizumab-plus-immunotherapy-may-ease-house-dust-mite-2026a1000czi?src=rss

27/04/2026

smay be a for developing later in , according to new research published in the Journal of . https://www.medscape.com/viewarticle/infants-colic-show-increased-risk-food-allergies-study-finds-2026a1000d84?src=rss

27/04/2026

has ⁠received European Commission approval for its ⁠drug
: the first ‌targeted ‌treatment approved for , ⁠offering a ‌unique ⁠approach to CSU ‌treatment in a pill taken twice daily ‌without ‌any lab monitoring required. https://www.medscape.com/s/viewarticle/novartis-receives-european-commissionapproval-rhapsido-skin-2026a1000d8q?ecd=a2a

27/04/2026

IL-9 and Blimp-1 protect the transcriptional identity of group 2 innate lymphocytes in . Open Access. https://interasma.org/2026/04/27/il-9-and-blimp-1-protect-the-transcriptional-identity-of-group-2-innate-lymphocytes-in-allergic-asthma/

27/04/2026

Long-Term Treatment Is Not Associated with an Increased Overall Risk of in Adults with Moderate-to-Severe : Results from an Open-Label 5-Year Extension Study. Open Access. https://ivancevichmd.blogspot.com/2026/04/long-term-dupilumab-treatment-is-not.html

27/04/2026

in Individuals Over 60 Years: A Comparative Analysis Across . Open Access. https://interasma.org/2026/04/27/asthma-in-individuals-over-60-years-a-comparative-analysis-across-age-subgroups/

27/04/2026

World Allergy Organization Journal (Volume 19, Issue 5) - Published Articles Alert - April 26, 2026
Dear Colleague,
Below please find the 5 articles that published in the above issue since your last alert on April 20, 2026:

Real-life lessons on omalizumab and food allergy: The potential for unexplored outcomes.
Lucia Lo Scalzo, Francesca Galletta, Arianna Cafarotti, Ulugbek Nurmatov, Ludger Klimek, Alessandro Fiocchi, Stefania Arasi.
worldallergyorganizationjournal.org/article/S1939-4551(26)00223-1/fulltext

Analysis and validation of diagnostic biomarkers and immune cell infiltration characteristics in chronic spontaneous urticaria and autophagy based on machine learning.
Yuxu Yao, Lijun Deng, Yin Hu, Yuxin Lin, Jialu Chen, Zhenzhong Lu, Jiang Ji, Qingqing Jiao.
worldallergyorganizationjournal.org/article/S1939-4551(26)00218-8/fulltext

Efficacy predictions for omalizumab treatment based on basophil CD203c expression in patients with allergic rhinitis by basophil activation test -- a real-life, pilot study.
Zhan Zhao, Huidong Chen, Tianyi Liu, Jun Hong, Yuqin Deng, Qingquan Hua.
worldallergyorganizationjournal.org/article/S1939-4551(26)00221-8/fulltext

Clinical remission in allergy and clinical immunology practice: State of the art and World Allergy Organization (WAO) call to action.
Mário Morais-Almeida, Giorgio Walter Canonica, Pedro Giavina-Bianchi, Stefania Arasi, Marco Caminati, Alessandro Fiocchi, Luz S. Fonacier, Mara Giavina-Bianchi, R. Maximiliano Gómez, Sandra N. González-Diaz, Bryan L. Martin, José Antonio Ortega Martell, Helena Pitè, Philip Rouadi, Jorge Sánchez Caraballo, Rosalaura V. Villarreal-González, Johann Christian Virchow, Claus Bachert, Jonathan A. Bernstein, Antonella Cianferoni, Ignacio Dávila, Nicola A. Hanania, Enrico Heffler, Parameswaran Nair, Hae-Sim Park, Hirohisa Saito, Gilda Varricchi, Anahí Yáñez, Ignacio J. Ansotegui.
worldallergyorganizationjournal.org/article/S1939-4551(26)00216-4/fulltext

Short-term high-dose budesonide nasal spray for postoperative uncontrolled chronic rhinosinusitis: A randomized controlled trial.
Yueqi Li, Yang Liu, Jingwen Zhao, Xuelan Zeng, Zhixiang Tang, Yuting Liu, Cong Li, Jianbo Shi, Fenghong Chen.
worldallergyorganizationjournal.org/article/S1939-4551(26)00210-3/fulltext

View the latest issues at worldallergyorganizationjournal.org

27/04/2026

and predicts short- and long-term occurrence across asthma severities. Open Access. https://ivancevichmd.blogspot.com/2026/04/asthma-impairment-and-risk.html

Dirección

Avenida Juan B. Alberdi 2756
Buenos Aires
C1406GSQ

Teléfono

+541146126273

Página web

https://patient.consultoriomovil.net/patient/web/alberdi2756/3574/dr-ivancevich-juan-carlos

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Allergy, Asthma & Clinical Immunology publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.